Table 1.

Processes of care documented in patients with type 2 diabetes in general practice in Norway in 2014 (ROSA 4) and 2005 (ROSA 3)

Processes of care	2014 (n=9464) Percentages		2005 (n=5463) Percentages		Change from 2005 to 2014 with 95% CI‡ Percentage points
	Observed, with 95% CI†	Adjusted‡	Observed	Adjusted‡
HbA1c	86.4 (84.9 to 87.9)	86.8	91.8	91.3	−4.4 (−6.7 to −2.1)**
Blood pressure	87.4 (85.8 to 89.0)	88.1	89.7	88.7	−0.5 (−3.2 to 2.2)
Cholesterol	89.0 (86.8 to 91.2)	89.0	89.5	89.6	−0.6 (−3.7 to 2.4)
LDL	84.4 (81.1 to 87.7)	83.8	40.8	41.7	+42.1 (32.9 to 51.2)**
Creatinine/eGFR	93.2 (91.5 to 95.0)		NA
Weight	51.4 (46.7 to 56.1)	51.8	54.2	53.6	−1.8 (−12.7 to 9.1)
BMI	44.6 (40.0 to 49.3)	45.1	36.9	36.3	+8.8 (−1.9 to 19.5)
Smoking habits	79.0 (76.2 to 81.9)	79.6	56.0	54.6	+24.9 (18.3 to 31.5)**
Eye examination	61.0 (57.4 to 64.6)	62.3	71.5	69.4	−7.1 (−11.1 to −3.2)**
Albuminuria	30.3 (25.6 to 34.9)	31.3	37.9	36.1	−4.8 (−13.8 to 4.1)
Monofilament 10 g	25.9 (21.5 to 30.3)	28.1	18.7	15.8	+12.3 (6.6 to 17.9)**
Number of screening procedures for microvascular complications§					**
0	29.2 (25.7 to 32.8)	28.0	21.2	22.8	+5.2 (0.5 to 10.0)
1	36.3 (34.2 to 41.6)	35.5	41.6	43.0	−7.5 (−11.7 to −3.4)
2	22.5 (20.0 to 25.0)	23.0	25.7	24.6	−1.6 (−6.5 to 3.2)
3	12.0 (9.1 to 14.8)	13.4	11.6	9.6	+3.9 (−0.8 to 8.6)

*P≤0.01, **P≤0.001.

†Based on data as registered, 95% CIs adjusted for clustering within GP practices.

‡Adjusted for sex, age, counties and clustering within GP practices.

 §Screening procedures: eye examination, albuminuria and 10 g monofilament test.

BMI, body mass index; eGFR, estimated glomerular filtration rate; GP, general practitioner; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein; NA, not available; ROSA 3, Rogaland-Oslo-Salten study; ROSA 4, Rogaland-Oslo-Salten-Akershus-Hordaland study.